Huifang Shan

机构：Sichuan University, West China Hospital of Sichuan University

发表论文 14 篇 · 总被引 174 次 · h-index 8

代表论文

• Discovery of a PROTAC targeting ALK with in vivo activity (2021 · European Journal of Medicinal Chemistry · 被引 52)
• Discovery of a novel covalent CDK4/6 inhibitor based on palbociclib scaffold (2021 · European Journal of Medicinal Chemistry · 被引 23)
• Discovery of 4-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and orally active PI3K/mTOR dual inhibitors (2019 · European Journal of Medicinal Chemistry · 被引 18)
• Severe cutaneous adverse reactions due to antibiotics therapy: a pharmacovigilance analysis of FDA adverse event reporting system events (2023 · Expert Opinion on Drug Safety · 被引 14)
• Fabrication of Cu-doped molybdenum oxide for bifunctional SERS and photothermal conversion (2022 · Materials Chemistry and Physics · 被引 12)
• Targeting Cysteine Located Outside the Active Site: An Effective Strategy for Covalent ALKi Design (2021 · Journal of Medicinal Chemistry · 被引 11)